Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
duvelisib phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform small molecule NA drugbank , DGIDB Lymphocyte[MeSHID:D008214]
Cells[MeSHID:D002477]
Blood Cells[MeSHID:D001773]
B-Cell Lymphomas[MeSHID:D016393]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Bone Marrow[MeSHID:D001853]
Cardiac Arrest[MeSHID:D006323]
Lymphoma
Follicular[MeSHID:D008224]
Relapse[MeSHID:D012008]
Term Birth[MeSHID:D047929]
lymph nodes[MeSHID:D008198]
Disease[MeSHID:D004194]
Body tissue[MeSHID:D014024]
Blood[MeSHID:D001769]
Lymphoid leukemia[MeSHID:D007945]
leukemia[MeSHID:D007938]
Cancer Stem Cells[MeSHID:D014411]
Growth[MeSHID:D006128]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]		 1.23 approved,investigational inhibitor
duvelisib phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform small molecule NA drugbank , DGIDB Lymphocyte[MeSHID:D008214]
Cells[MeSHID:D002477]
Blood Cells[MeSHID:D001773]
B-Cell Lymphomas[MeSHID:D016393]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Bone Marrow[MeSHID:D001853]
Cardiac Arrest[MeSHID:D006323]
Lymphoma
Follicular[MeSHID:D008224]
Relapse[MeSHID:D012008]
Term Birth[MeSHID:D047929]
lymph nodes[MeSHID:D008198]
Disease[MeSHID:D004194]
Body tissue[MeSHID:D014024]
Blood[MeSHID:D001769]
Lymphoid leukemia[MeSHID:D007945]
leukemia[MeSHID:D007938]
Cancer Stem Cells[MeSHID:D014411]
Growth[MeSHID:D006128]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]		 0.76 approved,investigational inhibitor
click here to return to the previous page